Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride values.
about
Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a reviewFenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.Dyslipidaemia of obesity, metabolic syndrome and type 2 diabetes mellitus: the case for residual risk reduction after statin treatmentShort-term fenofibrate treatment reduces elevated plasma Lp-PLA2 mass and sVCAM-1 levels in a subcohort of hypertriglyceridemic GOLDN participants.Matrix metalloproteinases and diabetic vascular complications.Beneficial effects of the addition of fenofibrate to statin therapy in patients with acute coronary syndrome after percutaneous coronary interventions.Non-low-density lipoprotein cholesterol-associated actions of ezetimibe: an overview.Endothelial function, arterial stiffness and lipid lowering drugs.The importance of treating multiple cardiometabolic risk factors in patients with Type 2 diabetes.Pleiotropic effects and cholesterol-lowering therapy.AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types.Inflammation as a marker for the prediction of internal carotid artery restenosis following eversion endarterectomy--evidence from clinical studies.Effect of hypolipidemic treatment on emerging risk factors in mixed dyslipidemia: a randomized pilot trial.Micronized fenofibrate: a useful choice for the correction of dyslipidemia in metabolic syndrome and Type 2 diabetes.Impact of endograft material on the inflammatory response after elective endovascular abdominal aortic aneurysm repair.
P2860
Q28220294-29E21369-8CB8-439B-AD86-5AFEE7C86743Q33933474-6E4C060F-FC8D-4863-846C-94E21BE2929EQ35029623-E9A33FB9-D0F3-423E-ABBE-9359A23BC62FQ35111638-66526D53-9575-4D48-AF16-83911621B03BQ36081593-18D37CF9-E584-4E2E-92A6-833FAE835746Q36608415-715730EA-09E6-4D0F-ADB4-57096C01EA6BQ36653658-265BD6DE-8BDF-4450-B1D2-4C08DA21383DQ36936335-4C0EA279-6829-4ADB-8F31-3C1D53EA14C4Q37000746-8DC9FE4E-1060-4BDE-B3BB-190A44E07DE2Q37199617-7100DDC2-0580-4395-902F-F279EFE7EF7DQ37851958-F07857D5-6E32-49E3-9274-5E2AC877C252Q37923226-E5A390B3-934F-41BE-BBA6-08E2633C1EEDQ38452702-DBA1E478-0E8A-46F0-9265-F6BD10D1BF22Q40274682-2D30DB16-349E-4ACD-BB98-61204554A2D9Q40492148-87CADD05-9BF4-44EC-BB5B-113EB4E80F96
P2860
Effect of fenofibrate on serum inflammatory markers in patients with high triglyceride values.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Effect of fenofibrate on serum ...... with high triglyceride values.
@en
type
label
Effect of fenofibrate on serum ...... with high triglyceride values.
@en
prefLabel
Effect of fenofibrate on serum ...... with high triglyceride values.
@en
P2093
P2860
P1476
Effect of fenofibrate on serum ...... with high triglyceride values.
@en
P2093
Alexandros D Tselepis
Angeliki Kostoula
Anna Kakafika
Eleni Bairaktari
Moses Elisaf
Vasilis Tsimihodimos
P2860
P356
10.1177/107424840400900I105
P577
2004-03-01T00:00:00Z